After analysis of the data available on mortality", the members of the safety Committee, and follow-up have estimated that "there is no reason to change the protocol of clinical trials.
WHO announced on Wednesday the resumption of clinical trials with hydroxychloroquine, nine days after being suspended following the publication of a study in the prestigious medical journal The Lancet.
After analysis of the data available on mortality", the members of the safety Committee, and follow-up have estimated that "there is no reason to change the protocol" for clinical trials, announced the director general of the WHO, Tedros Adhanom Ghebreyesus, during a virtual press conference.
READ ALSO >> Hydroxychloroquine : Olivier Véran wrote to The Lancet about the study controversial
Your support is essential. Subscribe for $ 1 support UsThe world health Organization was suspended on may 25, the clinical trials it conducts in several countries as a precaution. The organization has launched more than two months of testing regarding, among others, hydroxychloroquine, dubbed the "Solidarity", with the aim of finding an effective treatment against the Covid-19. "More than 400 hospitals in 35 countries, actively recruiting patients, and nearly 3 500 patients have been recruited from 17 countries", was described by the boss of WHO.
"Pretty confident"
"We are now quite confident about the fact of not having found differences in mortality," said Wednesday, Soumya Swaminathan, scientist-in-chief WHO, during a virtual press conference from the headquarters of the organization in Geneva.
The executive Group of the trial Solidarity, which represents the participating countries, "has received this recommendation and approved the continuation of all the dimensions of testing, including hydroxychloroquine, has also said Tedros Adhanom Ghebreyesus. "The executive Group will communicate with the principal researchers in charge of the trial about the recovery of dimension hydroxychloroquine of the test", he detailed.
Read our complete file
Covid-19 : hydroxychloroquine
autopsies to better understand the effects of the Covid-19 Hydroxychloroquine : Olivier Véran wrote to The Lancet about the study controversial Didier Raoult-pinned by the national Agency of medicine, the College of physicians enteredPublished may 22 in The Lancet, the study is based on data from 96 000 patients hospitalized between December and April in 671 hospitals, and compares the state of those who have received the treatment to that of patients who have not had.
Date Of Update: 03 June 2020, 19:58
